5
UGC
Summary - A new market study, titled “Healthcare Artificial Intelligence (AI) - Global Market Outlook (2017-(2017-2026))” has been featured on WiseGuy Reports.According to Stratistics MRC, the Global Healthcare Artificial Intelligence (AI) Market is accounted for $0.95 billion in 2017 and is expected to reach $19.25 billion by 2026 growing at a CAGR of 39.7% during the forecast period.Rising applications of artificial intelligence and advancements in data analytics are some of the factors fueling the market growth.However, high capital requirement is hindering the market growth.On the basis of End User, Hospital & Diagnostic Centers has witnessing the significant growth during the forecast period due to rising implementation of artificial intelligence technology for collection of data of patient to support decision making in hospital workflow has considerably enhanced outcomes, reduced wait times and costs are some of the factors fueling the market growth.Based on geography, Asia Pacific holds the largest market share during the forecast period due to increasing R expenditure, developments in pharmaceutical and biotechnology sectors, existence of huge patient pool will generate demand for improved healthcare services and growing disposable income are some of the factors driving the market growth in this region.Some of the key players profiled in the Healthcare Artificial Intelligence (AI) Market include Zebra Medical Vision Ltd, Sophia Genetics, Enlitic, Inc., Butterfly Network, Inc, Cyrcadia Health Inc., IBM (Watson Health), iCarbonX, Insilico Medicine, Inc., Lifegraph, Welltok, AiCure, APIXIO, Inc. and Atomwise, Inc.Technologies Covered:• Natural Language Processing• Querying Method• Machine Learning• Context Aware Processing• Deep LearningComponents Covered:• Hardware• Software• ServicesAlso Read: https://www.newsmaker.com.au/news/378931/global-healthcare-artificial-intelligence-ai-market-analysis-2020-forecasts-to-2026#.X18eTJdR3IUApplications Covered:• Hospital workflow• Virtual Assistants• Medical Imaging & diagnosis• Therapy planning• Drug discovery• Wearables• Robot-assisted Surgery• Dosage Error Reduction• Clinical Trial Participant Identifier• Automated Image Diagnosis• Fraud DetectionEnd Users Covered:• Academic & Research Laboratories• Hospital & Diagnostic Centers• Pharmaceutical & Biotechnology CompaniesRegions Covered:• North Americao USo Canadao Mexico• Europeo Germanyo UKo Italyo Franceo Spaino Rest of Europe• Asia Pacifico Japano Chinao Indiao Australiao New Zealando South Koreao Rest of Asia Pacific• South Americao Argentinao Brazilo Chileo Rest of South America• Middle East & Africao Saudi Arabiao UAEo Qataro South Africao Rest of Middle East & AfricaWhat our report offers:- Market share assessments for the regional and country level segments- Strategic recommendations for the new entrants- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.- Strategic recommendations in key business segments based on the market estimations- Competitive landscaping mapping the key common trends- Company profiling with detailed strategies, financials, and recent developments- Supply chain trends mapping the latest technological advancementsFree Customization Offerings:All the customers of this report will be entitled to receive one of the following free customization options:• Company Profilingo Comprehensive profiling of additional market players (up to 3)o SWOT Analysis of key players (up to 3)• Regional Segmentationo Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)• Competitive BenchmarkingBenchmarking of key players based on product portfolio, geographical presence, and strategic alliances FOR MORE DETAILS: https://www.wiseguyreports.com/reports/4133589-healthcare-artificial-intelligence-ai-global-market-outlook-2017-2026About Us:Wise Guy Reports is part of the Wise Guy Research Consultants Pvt.Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.Contact Us: NORAH TRENT                                                      [email protected]       Ph: +162-825-80070 (US)                          Ph: +44 2035002763 (UK)      
One of the most popular camera apps on iPhone is getting a huge upgrade alongside the iPhone 12 arrival, with Halide Mark II promising both greater pro-features as well as one-touch ways for everyday photographers to get better shots. The successor to Halide, the new app taps Apple’s new ProRAW on the iPhone 12 Pro and iPhone 12 Pro Max, … Continue reading
9
What is QLED? We run through everything that makes Samsung's premium QLED TVs so bright and beautiful.
5
UGC
The latest trending report Global GigE Camera Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.The report will assist reader with better understanding and decision making.The GigE Camera market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.The global GigE Camera market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 840.6 million by 2025, from USD 601.9 million in 2019.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/27581-gige-camera-market-analysis-reportThe major players covered in GigE Camera are:Toshiba TeliAllied VisionMatroxSonyBaslerBaumerQualitasTeledyne DALSAPoint GreyJaiGEViCAMThe Imaging SourceIMPERXEdmund OpticsPixeLINKBy Type, GigE Camera market has been segmented intoLine Scan CameraArea Scan CameraBy Application, GigE Camera has been segmented into:IndustrialMedical and Life SciencesSecurity and SurveillanceGISIntelligent Transportation System (ITS)The report offers in-depth assessment of the growth and other aspects of the GigE Camera market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global GigE Camera Market @ https://www.decisiondatabases.com/contact/download-sample-27581The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe GigE Camera product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of GigE Camera, with price, sales, revenue and global market share of GigE Camera in 2018 and 2019.Chapter 3, the GigE Camera competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the GigE Camera breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, GigE Camera market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe GigE Camera sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global GigE Camera Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-27581All Camera Related Reports by DecisionDatabases.com @ https://goo.gl/LHYwK2About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/News Source – https://www.industrynewsengine.com/2020/10/03/global-gige-camera-market-worth-840-6-million-usd-by-2025/
UGC
Summary - A new market study, titled “Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts” has been featured on WiseGuy Reports.“Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze.The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.SNS Telecom & IT estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4.7 Billion in 2018 alone.Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of approximately 12% over the next three years.The “Big Data in the Healthcare & Pharmaceutical Industry: 2018 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies.The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2018 through to 2030.The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 37 use cases, 6 regions and 35 countries.Also Read: https://www.wfmj.com/story/42346791/big-data-in-healthcare-pharmaceutical-market-2020-strategy-analysis-business-overview-and-opportunities-to-2030The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.Topics CoveredThe report covers the following topics:- Big Data ecosystem- Market drivers and barriers- Enabling technologies, standardization and regulatory initiatives- Big Data analytics and implementation models- Business case, application areas and use cases in the healthcare and pharmaceutical industry- Over 40 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders- Future roadmap and value chain- Profiles and strategies of over 270 leading and emerging Big Data ecosystem players- Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders- Market analysis and forecasts from 2018 till 2030Forecast SegmentationMarket forecasts are provided for each of the following submarkets and their subcategories: Hardware, Software & Professional Services- Hardware- Software- Professional ServicesHorizontal Submarkets- Storage & Compute Infrastructure- Networking Infrastructure- Hadoop & Infrastructure Software- SQL- NoSQL- Analytic Platforms & Applications- Cloud Platforms- Professional Services Application Areas- Pharmaceutical & Medical Products- Core Healthcare Operations- Healthcare Support, Awareness & Disease Prevention- Health Insurance & Payer Services- Marketing, Sales & Other Applications Use Cases- Drug Discovery, Design & Development- Medical Product Design & Development- Clinical Development & Trials- Precision Medicine & Genomics- Manufacturing & Supply Chain Management- Post-Market Surveillance & Pharmacovigilance- Medical Product Fault Monitoring- Clinical Decision Support- Care Coordination & Delivery Management- CER (Comparative Effectiveness Research) & Observational Evidence- Personalized Healthcare & Targeted Treatments- Data-Driven Preventive Care & Health Interventions- Surgical Practice & Complex Medical Procedures- Pathology, Medical Imaging & Other Medical Tests- Proactive & Remote Patient Monitoring- Predictive Maintenance of Medical Equipment- Pharmacy Services- Self-Care & Lifestyle Support- Digital Therapeutics- Medication Adherence & Management- Vaccine Development & Promotion- Population Health Management- Connected Health Communities & Medical Knowledge Dissemination- Epidemiology & Disease Surveillance- Health Policy Decision Making- Controlling Substance Abuse & Addiction- Increasing Awareness & Accessible Healthcare- Health Insurance Claims Processing & Management- Fraud & Abuse Prevention- Proactive Patient Engagement- Accountable & Value-Based Care- Data-Driven Health Insurance Premiums- Marketing & Sales- Administrative & Customer Services- Finance & Risk Management- Healthcare Data Monetization- Other Use CasesRegional Markets- Asia Pacific- Eastern Europe- Latin & Central America- Middle East & Africa- North America- Western Europe Country Markets- Argentina, Australia, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Taiwan, Thailand, UAE, UK, USAKey Questions AnsweredThe report provides answers to the following key questions:- How big is the Big Data opportunity in the healthcare and pharmaceutical industry?- How is the market evolving by segment and region?- What will the market size be in 2021, and at what rate will it grow?- What trends, challenges and barriers are influencing its growth?- Who are the key Big Data software, hardware and services vendors, and what are their strategies?- How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?- What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?- Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?Key FindingsThe report has the following key findings:- In 2018, Big Data vendors will pocket nearly $4.7 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry.
UGC
 The growth of the market is attributed to the increasing geriatric population and subsequent growth in global disease incidence, favorable regulations and government initiatives & investments, the advantages of digital X-ray systems, and technological advancements and product development.The Digital X-ray Market  is expected to reach USD 13.04 billion by 2023 from USD 8.68 billion in 2018, at a CAGR of 8.5%.Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164Market Segmentation:-                                            Based on application, the Digital Radiography Market is segmented into general radiography, dental applications, fluoroscopy, and mammography.In 2018, the general radiography segment is expected to account for the largest share of the digital X-ray market.The growth in this market is mainly driven by the rising prevalence of diseases like tuberculosis, osteoporosis, and CVD; growing aging population; and product launches.By technology, the Digital Radiography Market is segmented into direct radiography and computed radiography.Faxitron Bioptics is a leader in digital specimen radiography.This acquisition enabled Hologic to expand their interventional breast business.In May 2018, Siemens Healthineers partnered with ScreenPoint Medical.This partnership helped Siemens to develop AI-based applications for breast imaging.In April 2018, Konica Minolta, Inc launched KDR Primary Digital Radiography System.In March 2018, Hologic partnered with Philips.
UGC
Central Pontine Myelinolysis Market Information: By Diagnosis (Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), Electroencephalography, Others) By Treatment (Vitamin Supplementation, Electrolyte Mainainence, others)) By End Users - Global Forecast till 2023Central Pontine Myelinolysis Market SegmentationThe global central pontine myelinolysis market has been segmented on the basis of diagnosis, treatment, and end users.Based on diagnosis, the market has been segmented as Magnetic Resonance Imaging (MRI), Computerized Tomography (CT), electroencephalography and others.Based on treatment, the market has been segmented as vitamin supplementation, electrolyte maintenance and others.Based on the end users, the central pontine myelinolysis market has been segmented as hospitals & clinics, academic and research and others.Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4580Central Pontine Myelinolysis Market Highlights:Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells.CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms.Market OverviewThese neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures etc.Serious progressive neurological symptoms are, progressive development of spastic tetraparesis, pseudobulbar palsy etc.The diagnosis segment of central pontine myelinolysis especially the Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is growing fast.The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.Global Central pontine myelinolysisFujifilm Holdings Corporation, GE Healthcare, Siemens Healthcare GmbH, Philips Healthcare (Koninklijke Philips N.V.), Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others.Central Pontine Myelinolysis Market Regional AnalysisEurope is the second largest central pontine myelinolysis market in the world due to high income and healthcare penetration.UK is expected to be the fastest growing market.Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care.
UGC
Market SegmentationThe global Image Guided Radiotherapy market has been segmented by types, technology, devices, application, and end users.In terms of types, the market is segmented into soft-tissue imaging, lung MRI, simplifying cardiac MRI, simplifying MRI-conditional implant scans, and silent MRI scanning.In terms of technology, the market is segmented into radiation-based, non-radiation based systems, and others.Further, non-radiation based systems are segmented into ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4276In terms of devices, the market is segmented into X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography, and others.Such therapy is mostly used in the treatment of cancer such as lung cancer, skin cancer, and more.There have been some significant factors that are driving the global IGRT market, which has been covered in this report in a precise way.Global IGRT Market: Drivers & TrendsAccording to the reports by MRFR, the global Image Guided Radiotherapy Market is experiencing a whistle-stop growth owing to the factors such as the increasing prevalence of cancer and rapid development on the cancer treatments.These developing therapies for cancer can have huge demand in future, which can contribute substantially in the market growth over the assessment period.On the flip side, the high cost of the radiotherapy treatment & devices along with its side effects, can sluggish the growth of global IGRT market over the review period.Regional OutlookThe regional analysis of global Image Guided Radiotherapy market is carried out across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.The Americas is currently leading the market share as the presence of a vast patient population as well as increasing healthcare expenditure has made it possible.Apart from this, increasing awareness among people about radiotherapy treatments and well-developed technology have substantially fueled the global IGRT market growth.Europe holds the second largest market and has a noticeable share as well.
UGC
The latest trending report Global Fixtured Electric Nutrunner Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.The report will assist reader with better understanding and decision making.The global Fixtured Electric Nutrunner market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1%% in the forecast period of 2020 to 2025 and will expected to reach USD 178.9 million by 2025, from USD 146.8 million in 2019.The Fixtured Electric Nutrunner market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/43561-fixtured-electric-nutrunner-industry-analysis-reportThe major players covered in Fixtured Electric Nutrunner are:    Sunny Optical Technology    Jenoptik    K Laser Technology    DiYPRO Co.,Ltd    Dioptic GmbH    Nihon Tokushu Kogaku Jushi (NTKJ)    H & K reflex GmbH    Knight Optical    Fresnel Technologies    Sud-Optik Schirmer GmbH    Edmund Optics    Shandong YuYing Optical Instrument    Shenzhen Haiwang SensorsBy Type, Fixtured Electric Nutrunner market has been segmented into    Imaging Fixtured Electric Nutrunneres    Non-Imaging Fixtured Electric NutrunneresBy Application, Fixtured Electric Nutrunner has been segmented into:    Photography    Lighting    Projection    Vision Correction    Solar Power    OthersThe report offers in-depth assessment of the growth and other aspects of the Fixtured Electric Nutrunner market in important countries (regions), including:North America (United States, Canada and Mexico)Europe (Germany, France, UK, Russia and Italy)Asia-Pacific (China, Japan, Korea, India and Southeast Asia)South America (Brazil, Argentina, etc.)Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Fixtured Electric Nutrunner Market @ https://www.decisiondatabases.com/contact/download-sample-43561The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Fixtured Electric Nutrunner product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Fixtured Electric Nutrunner, with price, sales, revenue and global market share of Fixtured Electric Nutrunner in 2018 and 2019.Chapter 3, the Fixtured Electric Nutrunner competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Fixtured Electric Nutrunner breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Fixtured Electric Nutrunner market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Fixtured Electric Nutrunner sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Fixtured Electric Nutrunner Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-43561Other Reports by DecisionDatabases.com:Global Handheld Nutrunner Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024Global Handheld Electric Nutrunner Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025Global Electric Nutrunner Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com
UGC
Ureteral Obstruction Market Share, Growth And Trends Analysis By Type (Acute, Chronic) By Diagnosis (Ultrasound, Bladder Catheterization, Others) By Treatment (Surgery, Drugs) By Equipment (Devices, Consumables, Others) By End Users - Global Forecast Till 2023Ureteral Obstruction Market Segmentation:The global ureteral obstruction market is segmented based on type, diagnosis, treatment, equipment and end users.Based on type, the market has been segmented as acute and chronic.Based on the diagnosis, the market has been segmented as ultrasound, bladder catheterization, computed tomography (CT), magnetic resonance imaging (MRI), voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and others.Based on the treatment, the Ureteral Obstruction Market has been segmented as surgery (ureteral stent, nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and drugs (antibiotics, pain killers, others).Based on the equipment, the market has been segmented as devices (catheters, stents, others) and consumables (diagnostic reagents, urinary sample collectors, others) and others.Based on the end users, the market has been segmented as hospitals and clinics, research, others.Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/4041Ureteral Obstruction Market OverviewThe market for ureteral obstruction is highly fragmented due to large number of players especially in the devices segment which has put pressure on the profit margin, rise of low quality and low-cost products especially catheters which reduces the market of high-quality products.Considering all these factors, the ureteral obstruction market is expected to grow at a CAGR of 8.5 % during 2017-2023.The global Ureteral Obstruction Market is growing at a rate of 8.5 % and is expected show a similar trend during the forecast period.Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through the urinary tract, which may be complete or partial.
UGC
Global Needle Biopsy Market: Drivers & TrendsThe Global Needle Biopsy Market is majorly driven by technological advancements in biopsy devices, which includes vacuum biopsy devices.This factor is boosting the global needle biopsy market.As per the research by MRFR, the factors such as the presence of untapped opportunities mainly in developing regions is also anticipated to boost the global needle biopsy market substantially in the years to come.Apart from this, more factors such as inactive lifestyle and unhealthy dietary habits with increasing consumption of alcohol and tobacco have escalated occurrence rate of cancer globally will boost industry growth over the coming years.Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/3830On top of it, factors such as rising awareness related to cancer diagnosis coupled with the growing demand for advanced diagnostic procedures are also projected to impact the global needle biopsy market.Even the key market players are continually focusing on developing cost-effective biopsy devices to gain a significant share of the global needle biopsy market in developing regions.On the flip side, the development of ultrasensitive imaging technologies such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) and more can hold back the expected growth of the global needle biopsy market during the assessment period.Market InsightsThe Needle Biopsy Market is cementing its foothold at a CAGR of 5.2 % by gaining a valuation of $677 million by 2023, asserts Market Research Future reports.The market is gaining traction generated by diseases such as cancer and several infections across the globe.A Biopsy is a medical test that is commonly performed by a surgeon, interventional radiologists, or an interventional cardiologist.The entire process is generally examined under a microscope by a pathologist or can be analyzed chemically.Market SegmentationThe Global Needle Biopsy Market has been segmented by type and applications.In terms of type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, and image-guided biopsy.In terms of utility, the market has been segmented as disposable and reusable.In terms of applications, the market has been segmented as tumor, infection, inflammation, and others.Regional OutlookThe regional analysis of the Global Needle Biopsy Market includes North America, Europe, Asia Pacific, and Middle East & Africa.In the North American region, the US is reaping the benefits of favorable reimbursement scenarios and higher expenditure on healthcare.
UGC
Segmentation:Saudi Arabia, the medical devices market, is segmented based on product type, therapeutic application, end user, and region.By end user, the market is categorized into hospitals, ambulatory, and home.By therapeutic application, the market is segmented into general surgery, respiratory, diagnostic imaging, orthopedics, dental, cardiovascular, neurology, nephrology and urology, ear-nose-throat (ENT), ophthalmology, and others.By product type, the market is segmented into monitoring devices, diagnostic molecular devices, diagnostic devices, drug delivery devices, bio implants and stimulation devices, surgical devices, automation and robotics, and others.Request Free sample Copy at: https://www.marketresearchfuture.com/sample_request/2801Regional Analysis:The healthcare sector in Saudi Arabia is diving into the private and state.However, local manufacturing systems are limited to consumables and ordinary products.The U.S. and European countries dominate the imports of the medical device market of the country.OverviewThe healthcare sector and medical devices industry is changing robustly due to advancements in neurology, cardiology, orthopedics, medical imaging, and oncology.The robust advancements in the ECG, pacemakers, and other devices including brain monitoring devices, are benefiting several patients.Additionally, the introduction of newer products is estimated to benefit market growth and witness the most worthwhile opportunities in the coming years.Further, widening applications and knowledge of using medical devices for treatment and screening diseases are driving growth of the Saudi Arabia medical devices market.The other factors driving the market growth are robust investment by private, and the public sector is fueling growth of the medical devices market.
UGC
The report precisely describes key obstacles and opportunities for growth, while drawing out competitive standing of market majors, including their portfolio and growth strategies.Bile Duct Cancer Market Research Report, By Type (Intrahepatic, Extrahepatic), Diagnosis (Blood Tests, Abdominal Imaging, Surgery), By Treatment (Chemotherapy, Radiotherapy), By End User (Hospital& Clinics, Academic Institutes) – Global Forecast till 2023Market AnalysisThe global Bile Duct Cancer Market is likely to grow at a 9.2% CAGR between 2017- 2023, according to the recent Market Research Future (MRFR) report.Some of its symptoms include nausea and vomiting, fever, loss of appetite, weight loss, abdominal pain, dark urine, light-colored stools, jaundice, and intensely itchy skin.Various factors are adding to the global bile duct cancer market share.These factors, as per the new MRFR report, include increasing cases of bile duct cancer, rising healthcare expenditures, rising awareness of bile duct cancer, increasing investments in the research and development activities for treatment procedures, and technological advances in the healthcare sector.On the contrary, high treatment costs, long duration in drug approvals, low healthcare expenditure, and related side effects are factors that may limit the bile duct cancer market growth over the forecast period.Market SegmentationThe MRFR report provides an inclusive segmental analysis of the global bile duct cancer market based on end users, type, treatment, and diagnosis.By type, the bile duct cancer market is segmented into extrahepatic, intrahepatic, and others.By diagnosis, the bile duct cancer market is segmented into surgery, abdominal imaging, blood tests, and others.The abdominal imaging segment is again segmented into magnetic resonance cholangiopancreatography (MRCP), percutaneous transhepatic cholangiography (PTC), endoscopic retrograde cholangiopancreatography (ERCP), and others.By treatment, the bile duct cancer market is segmented into radiotherapy, chemotherapy, and others.The chemotherapy segment is again segmented into cisplatin, gemcitabine, 5-fluorouracil, and others.Additional factors adding market growth include growing public-private investments, increasing awareness programs, and ongoing research activities.
More

Top